ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,840.00
      -0.03%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      85.67
      -0.97%
      Bitcoin
      57,138.37
      2.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Synthetic Biologics Inc (SYN)

      7. Synthetic Biologics Inc (SYN) News

      SYN

      Synthetic Biologics (SYN)

      Synthetic Biologics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:SYN
      DateTimeSourceHeadlineSymbolCompany
      09/21/20156:57AMPR Newswire (US)Synthetic Biologics Reports First Analysis Demonstrating SYN-004's Ability to Protect the Microbiome from Damage Caused by IV...AMEX:SYNSynthetic Biologics Inc
      09/04/20152:39PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:SYNSynthetic Biologics Inc
      09/04/20152:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
      09/03/20154:16PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      08/24/201511:10AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)AMEX:SYNSynthetic Biologics Inc
      08/19/20156:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)AMEX:SYNSynthetic Biologics Inc
      08/19/20156:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)AMEX:SYNSynthetic Biologics Inc
      08/10/20151:50PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:SYNSynthetic Biologics Inc
      08/10/20151:48PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:SYNSynthetic Biologics Inc
      08/10/20151:44PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:SYNSynthetic Biologics Inc
      08/10/20151:08PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
      08/10/20156:51AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      08/10/20156:45AMPR Newswire (US)Synthetic Biologics Reports Second Quarter 2015 Financial Results and Operational HighlightsAMEX:SYNSynthetic Biologics Inc
      08/10/20156:36AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      08/10/20156:30AMPR Newswire (US)Intrexon and Synthetic Biologics Enter ECC to Develop Novel Biotherapeutics for Treatment of PhenylketonuriaAMEX:SYNSynthetic Biologics Inc
      08/05/20159:10AMPR Newswire (US)Biotechnology Stocks Technical Data -- Keryx Biopharma, Idera Pharma, Synthetic Biologics, OvaScience and Infinity PharmaAMEX:SYNSynthetic Biologics Inc
      07/29/20156:57AMPR Newswire (US)Synthetic Biologics to Report Second Quarter Results on August 10, 2015AMEX:SYNSynthetic Biologics Inc
      07/21/20159:24AMPR Newswire (US)Synthetic Biologics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment OptionAMEX:SYNSynthetic Biologics Inc
      07/17/20156:02AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      07/17/20156:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:SYNSynthetic Biologics Inc
      07/16/20158:55AMPR Newswire (US)Synthetic Biologics Announces Pricing of $40.0 Million Public OfferingAMEX:SYNSynthetic Biologics Inc
      07/15/20154:14PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:SYNSynthetic Biologics Inc
      07/15/20154:05PMPR Newswire (US)Synthetic Biologics Announces Public Offering of Common StockAMEX:SYNSynthetic Biologics Inc
      07/09/20156:05AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      06/29/20156:57AMPR Newswire (US)Synthetic Biologics' Initiates SYN-010 Phase 2 Clinical Trial to Treat Irritable Bowel Syndrome with Constipation (IBS-C)AMEX:SYNSynthetic Biologics Inc
      06/16/20158:02AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      06/12/20156:58AMPR Newswire (US)First Participant Dosed in Synthetic Biologics' Second Phase 2a Clinical Trial to Protect the Microbiome and Prevent C. diffi...AMEX:SYNSynthetic Biologics Inc
      06/03/20156:28AMPR Newswire (US)Synthetic Biologics Presents Initial Data Validating Platform Expansion to Cover Carbapenem AntibioticsAMEX:SYNSynthetic Biologics Inc
      06/02/20156:57AMPR Newswire (US)Synthetic Biologics Expands Clinical & Regulatory Leadership Team with Addition of Klaus Gottlieb, MD, FACGAMEX:SYNSynthetic Biologics Inc
      06/01/20154:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
       Showing the most relevant articles for your search:AMEX:SYN